Patents by Inventor Santosh Khedkar

Santosh Khedkar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USE OF SMALL MOLECULE INHIBITORS TO KLF10 FOR MODULATION OF T REGULATORY CELLS AND CANCER IMMUNOTHERAPY
    Publication number: 20220185801
    Abstract: The invention relates to compositions and methods for inhibiting Krüppel-like Factor 10 (KLF10) for modulation of T regulatory cells and cancer immunotherapy.
    Type: Application
    Filed: January 28, 2022
    Publication date: June 16, 2022
    Applicants: The Brigham and Women's Hospital, Inc., Beth Israel Deaconess Medical Center, Inc.
    Inventors: Mark FEINBERG, Santosh A. KHEDKAR
  • Use of small molecule inhibitors to KLF10 for modulation of T regulatory cells and cancer immunotherapy
    Patent number: 11267807
    Abstract: The invention relates to compositions and methods for inhibiting Krüppel-like Factor 10 (KLF10) for modulation of T regulatory cells and cancer immunotherapy.
    Type: Grant
    Filed: October 28, 2016
    Date of Patent: March 8, 2022
    Assignees: The Brigham and Women's Hospital, Inc., Beth Isreal Deaconess Medical Center, Inc.
    Inventors: Mark Feinberg, Santosh A. Khedkar
  • UBE2K MODULATORS AND METHODS FOR THEIR USE
    Publication number: 20220002255
    Abstract: Provided are compounds of Formula (I): and pharmaceutically acceptable salts and compositions thereof, which are useful for treating conditions associated with modulation of UBE2K.
    Type: Application
    Filed: July 7, 2021
    Publication date: January 6, 2022
    Inventors: Vivek K. Vishnudas, Dinesh U. Chimmanamada, Santosh A. Khedkar
  • UBE2K modulators and methods for their use
    Patent number: 11091447
    Abstract: Provided are compounds of Formula (I): and pharmaceutically acceptable salts and compositions thereof, which are useful for treating conditions associated with modulation of UBE2K.
    Type: Grant
    Filed: December 31, 2020
    Date of Patent: August 17, 2021
    Assignee: Berg LLC
    Inventors: Vivek K. Vishnudas, Dinesh U. Chimmanamada, Santosh A. Khedkar
  • UBE2K MODULATORS AND METHODS FOR THEIR USE
    Publication number: 20210214320
    Abstract: Provided are compounds of Formula (I): and pharmaceutically acceptable salts and compositions thereof, which are useful for treating conditions associated with modulation of UBE2K.
    Type: Application
    Filed: December 31, 2020
    Publication date: July 15, 2021
    Inventors: Vivek K. Vishnudas, Dinesh U. Chimmanamada, Santosh A. Khedkar
  • Vitamin D receptor agonists and uses thereof
    Patent number: 9499488
    Abstract: This invention features vitamin D receptor agonists, and their use in treating bone disorders, cardiovascular disease, hyperparathyroidism, immune disorders, proliferative disease, renal disease, and thrombosis.
    Type: Grant
    Filed: July 11, 2012
    Date of Patent: November 22, 2016
    Assignees: Beth Israel Deaconess Medical Center, Inc., The General Hospital Corporation
    Inventors: Peter M. Kang, S. Ananth Karumanchi, Santosh Khedkar, Alan Rigby, Ravi I. Thadhani
  • VITAMIN D RECEPTOR AGONISTS AND USES THEREOF
    Publication number: 20140378507
    Abstract: This invention features vitamin D receptor agonists, and their use in treating bone disorders, cardiovascular disease, hyperparathyroidism, immune disorders, proliferative disease, renal disease, and thrombosis.
    Type: Application
    Filed: July 11, 2012
    Publication date: December 25, 2014
    Applicant: Beth Israel Deaconess Medical Center, In.
    Inventors: Peter Kang, Ananth Karumanchi, Santosh Khedkar, Alan Rigby, Ravi I. Thadhani